非囊性纤维化支气管扩张症的免疫过敏类型与高致敏频率
研究纳入亚洲与英国238例支气管扩张症患者,匹配年龄、性别和严重度,检测常见过敏原特异性IgE及气道免疫炎症状态。发现多重过敏原致敏频率高,超过过敏性鼻炎对照队列,且致敏与肺功能下降和更严重疾病相关。致敏患者可分为真菌驱动促炎型和屋尘螨驱动趋化因子主导型,前者临床结局更差。
要点
- 支气管扩张症患者中多重过敏原致敏频率高,且与肺功能下降和疾病严重度相关。
- 致敏患者可分为真菌驱动促炎型和屋尘螨驱动趋化因子主导型,前者临床结局更差。
- 致敏状态是可治疗特征,改善内表型分型有助于靶向治疗和未来研究分层。
核心结论
- 非囊性纤维化支气管扩张症患者中过敏致敏高频出现,且与不良临床结局相关。
- 致敏患者可分为两种免疫过敏类型,真菌驱动型临床结局更差。
研究设计与样本
- 招募亚洲(新加坡和马来西亚)与英国(苏格兰)支气管扩张症患者共238例,按年龄、性别和严重度匹配形成队列。
- 检测针对常见过敏原的特异性IgE,结合气道免疫炎症状态,并与临床结局关联分析。
主要发现
- 多重过敏原致敏频率高,超过过敏性鼻炎对照队列(n=149)。
- 致敏与肺功能下降和更严重疾病相关。
- 致敏支气管扩张症分为真菌驱动促炎型和屋尘螨驱动趋化因子主导型,前者临床结局更差。
临床怎么用
- 对支气管扩张症患者应关注过敏致敏状态,将其作为可治疗特征进行干预。
- 改善致敏患者的内表型分型,有助于在适当患者中实施靶向治疗和未来研究分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Allergic sensitization is associated with poor clinical outcomes in asthma, chronic obstructive pulmonary disease, and cystic fibrosis; however, its presence, frequency, and clinical significance in non-cystic fibrosis bronchiectasis remain unclear. OBJECTIVES: To determine the frequency and geographic variability that exists in a sensitization pattern to common and specific allergens, including house dust mite and fungi, and to correlate such patterns to airway immune-inflammatory status and clinical outcomes in bronchiectasis. METHODS: Patients with bronchiectasis were recruited in Asia (Singapore and Malaysia) and the United Kingdom (Scotland) (n = 238), forming the Cohort of Asian and Matched European Bronchiectasis, which matched recruited patients on age, sex, and bronchiectasis severity. Specific IgE response against a range of common allergens was determined, combined with airway immune-inflammatory status and correlated to clinical outcomes. Clinically relevant patient clusters, based on sensitization pattern and airway immune profiles ("immunoallertypes"), were determined. MEASUREMENTS AND MAIN RESULTS: A high frequency of sensitization to multiple allergens was detected in bronchiectasis, exceeding that in a comparator cohort with allergic rhinitis (n = 149). Sensitization was associated with poor clinical outcomes, including decreased pulmonary function and more severe disease. "Sensitized bronchiectasis" was classified into two immunoallertypes: one fungal driven and proinflammatory, the other house dust mite driven and chemokine dominant, with the former demonstrating poorer clinical outcome. CONCLUSIONS: Allergic sensitization occurs at high frequency in patients with bronchiectasis recruited from different global centers. Improving endophenotyping of sensitized bronchiectasis, a clinically significant state, and a "treatable trait" permits therapeutic intervention in appropriate patients, and may allow improved stratification in future bronchiectasis research and clinical trials.
引用
- Mac Aogáin M, Tiew PY, Lim AYH, et al. Distinct "Immunoallertypes" of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis Bronchiectasis. Am J Respir Crit Care Med. 2019. PMID: 30265843. doi:10.1164/rccm.201807-1355OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。